AMSTERDAM — For patients with diffuse cutaneous systemic sclerosis, an autoimmune disease for which there are few treatment options, lenabasum (JBT-101, Corbus Pharmaceuticals) shows potential, new ...

Please provide your email address to receive an email when new articles are posted on . Black patients with systemic sclerosis had multiple poor prognostic features compared with non-Black patients, ...

A 57-YEAR old British-Iranian woman was told by a skincare specialist that she had a "disease that turns you into stone". When Asal Shirazi was 39 she was told she had four to six months to live after ...

ATLANTA — New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that Black people living with systemic sclerosis may have more severe ...

Please provide your email address to receive an email when new articles are posted on . Patients showed no difference in skin fibrosis whether they were given low-dose oral glucocorticoids or not. One ...

Q: My son's hands started to swell more than a year ago, then his fingers and forearms got real hard. Then the skin around his mouth stated to wrinkle. After that he started to have difficulty ...

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that Black people living with systemic sclerosis may have more severe disease and ...

Rituximab effectively reduced skin sclerosis and appeared to have a beneficial effect on interstitial lung disease (ILD) for patients with systemic sclerosis (SSc) in a randomized, clinical trial. At ...

According to DataM Intelligence, "The Scleroderma Market Size reached US$ 2,384.73 million in 2024 and is expected to expand ...